MOLBSEMeghmani Organics LtdHighNeutral
Announced Thu, 14 May · 14:04 IST

Approval of Audited Financial Results for the Quarter and Year ended 31st March, 2026.

Pat Growth 25pctRelated Party TransactionsEbitda Margin ExpansionResults View source PDF

MOL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹54.00
prior close
₹55.09
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.6-4.1-4.7-4.3-2.6-8.6-7.7-9.3-9.3-5.1-9.4-8.1-13.0
Up moveDown movePending
AI summary

Meghmani Organics reported strong annual results for FY26. Standalone revenue grew 4.4% to Rs. 2,09,181 lakhs, while net profit surged 88.6% to Rs. 12,526 lakhs from Rs. 6,642 lakhs in FY25. Consolidated results showed a turnaround with net profit of Rs. 2,874 lakhs versus a loss of Rs. 1,060 lakhs in the prior year. Agrochemicals segment drove growth with 12.4% revenue increase, while the Pigment segment saw a 16.7% decline. The company invested Rs. 363 lakhs in a wind-solar hybrid power project through an associate company. The Board also approved a scheme to amalgamate two wholly-owned subsidiaries (Kilburn Chemicals and Meghmani Crop Nutrition) pending regulatory approvals. Statutory auditors issued unmodified opinions on both standalone and consolidated financials.

Likely market impact

The company delivered exceptional PAT growth of nearly 89% on standalone basis, significantly exceeding the 25% threshold. The turnaround in consolidated profitability and strong operating cash flow of Rs. 22,938 lakhs are positive signals for investors. However, the Pigment segment continues to underperform, and rising finance costs remain a concern.